People with HIV infection are often affected by viral hepatitis

Coinfection with viral hepatitis is common in people with HIV. In fact, in the United States about 25% of people with HIV are coinfected with HCV, and about 10% are coinfected with HBV.1,2 Those who inject drugs have an even higher risk, with 80% coinfection with HCV.1 HIV coinfection with either HBV or HCV can lead to serious medical complications, and for this reason, screening for HBV and HCV infection is imperative among HIV-infected persons.1,2

For more information, watch the webinar Evaluation and Management of HIV/HCV Coinfection.

Important facts about HIV coinfection with HBV or HCV:

  • Some forms of viral hepatitis are transmitted the same way as HIV–through unprotected sex and injection drug use.
  • Coinfection with viral hepatitis complicates the treatment and management of HIV infection.1 To learn more, visit our Treatment and monitoring page.
  • Hepatitis C progresses faster among people who also have HIV infection.1
  • HCV/HIV coinfection more than triples the risk for liver disease, liver failure, and liver-related death from HCV.1
  • For those who are not already infected with HBV, vaccination is recommended to prevent coinfection.1,2
  • While there is no vaccine for HCV, treatments are available and are continually improving, with fewer side effects and shorter treatment duration than in the past.

Screening for HBV and HCV infection is imperative among HIV-infected persons and highly recommended by the CDC, the NIH, and the HIVMA of the IDSA guidelines.2

Many patients don't realize they are at risk for HIV. Help your patients stay up to date with important information. Visit our Patient education tools page to discover patient-friendly resources.

CDC=Centers for Disease Control and Prevention; HBV=hepatitis B virus; HCV=hepatitis C virus; HIVMA=HIV Medicine Association; IDSA=Infectious Diseases Society of America; NIH=National Institute of Health.

References: 1. Centers for Disease Control and Prevention. HIV and viral hepatitis. Accessed April 19, 2017. 2. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Accessed April 19, 2017.